CO5140118A1 - Sales de piperidinas 4-substituidas y n-substituidas - Google Patents

Sales de piperidinas 4-substituidas y n-substituidas

Info

Publication number
CO5140118A1
CO5140118A1 CO99072637A CO99072637A CO5140118A1 CO 5140118 A1 CO5140118 A1 CO 5140118A1 CO 99072637 A CO99072637 A CO 99072637A CO 99072637 A CO99072637 A CO 99072637A CO 5140118 A1 CO5140118 A1 CO 5140118A1
Authority
CO
Colombia
Prior art keywords
alkyl
haloalkyl
hydrogen
independently
aralkyl
Prior art date
Application number
CO99072637A
Other languages
English (en)
Inventor
Donald Roy Hirschfeld
Denis John Kertesz
David Bernard Smith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO5140118A1 publication Critical patent/CO5140118A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto seleccionado de los compuestos de fórmula (I): <EMI FILE="99072637_1" ID="1" IMF=JPEG >en la que :uno de T y U es -N+R5- donde R5 es alquilo, haloalquilo, cianoalquilo, hidroxialquilo, alcoxialquilo, carboxialquilo, alcoxicarbonilalquilo, amidoalquilo, sulfonilaminoalquilo, o aralquilo y el otro es -CH-; X¯ es un anión farmacéuticamente aceptable; R1 y R2 son, independientemente uno de otro, hidrógeno o alquilo; m es un entero de 0 a 3 con la condición de que cuando T es -N+R5- entonces m es como mínimo 1; Ar y Ar1 son, independientemente uno de otro, arilo o heteroarilo; F es alquileno, alquenileno o un enlace; R es hidrógeno o alquilo; o R junto con bien R3 o R4 y los átomos a los que están unidos forman un carbociclo o un heterociclo; R3 y R4 son, independientemente uno de otro, hidrógeno, alquilo, alquenilo, haloalquilo, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, heteroarilo, heteroaralquilo, heterociclilo, heterociclilalquilo, heteroalquilo, o -(alquileno)-C(O)-Z donde Z es alquilo, haloalquilo, alcoxi, haloalquiloxi, hidroxi, amino, amino mono sustituido con alquilo, heteroalquilo, haloalquilo, cicloalquilo, cicloalquilalquilo o fenilo opcionalmente sustituido independientemente con uno, dos o tres sustituyentes seleccionados de alquilo, haloalquilo, halo, nitro, ciano, -OR(donde R es hidrógeno o alquilo), -NRR´ (donde R y R´ son independientemente uno de otro hidrógeno o alquilo), -COOR (donde R es hidrógeno o alquilo) o -CONR´R" (donde R´ y R" son independientemente seleccionados de hidrógeno o alquilo); ó amino disustituido independientemente con alquilo, alquenilo, heteroalquilo, haloalquilo, cicloalquilo, cicloalquilalquilo o fenilo opcionalmente sustituido como se ha definido anteriormente; arilo, aralquilo, ariloxi, aralquiloxi, heteroarilo, heteroariloxi, o heteroaralquiloxi; E es -C(O)N(R6)-, -S02N(R6)-, -N(R7)C(0)N(R6)-, -N(R7) S02N(R6)-, N(R7)C(S)N(R6)-, -N(R7)C(0)- o -N(R7)S02- donde; R6 y R7 son, independientemente uno de otro, hidrógeno, alquilo, acilo, haloalquilo, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, aralquenilo, heteroarilo, heteroaralquilo, heterocicloalquilo, heteroalquilo, o -(alquileno)-C(O)-Z, donde Z es alquilo, haloalquilo, alcoxi, haloalquiloxi, hidroxi, - 2 -amino, amino mono- o disustituido como se ha definido anteriormente, arilo, aralquilo, ariloxi, aralquiloxi, heteroarilo, heteroariloxi, o heteroaralquiloxi; Q es -CO- o una cadena de alquileno interrumpida opcionalmente por -C(O)-, -NR8, -O-, -S(O)0-2-, -C(O)N(R8)-, -N(R8)C(O)-, -N(R8)SO2-, -S02N(R8)-, -N(R9)C(O)N(R10)-, -N(R9)SO2N(R10)- o -N(R9)C(S)N(R10)- donde: R8, R9 y R10 son independientemente uno de otro, hidrógeno, alquilo, acilo, haloalquilo, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, aralquenilo, heteroarilo, heteroaralquilo, heterociclilalquilo, heteroalquilo, o -(alquileno)-C(O)-Z, donde Z es alquilo, haloalquilo, alcoxi, haloalquiloxi, hidroxi, amino, amino mono- o disustituido como se ha definido anteriormente, arilo, aralquilo, ariloxi, aralquiloxi, heteroarilo, heteroariloxi, o heteroaralquiloxi;y profármacos, isómeros individuales, mezclas de isómeros y sales farmacéuticamente aceptables de los mismos.
CO99072637A 1998-11-20 1999-11-18 Sales de piperidinas 4-substituidas y n-substituidas CO5140118A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10929398P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
CO5140118A1 true CO5140118A1 (es) 2002-03-22

Family

ID=22326896

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99072637A CO5140118A1 (es) 1998-11-20 1999-11-18 Sales de piperidinas 4-substituidas y n-substituidas

Country Status (20)

Country Link
US (1) US6342509B1 (es)
EP (1) EP1131290B1 (es)
JP (1) JP3421323B2 (es)
KR (1) KR20010081034A (es)
CN (1) CN1326440A (es)
AR (1) AR029151A1 (es)
AT (1) ATE386720T1 (es)
AU (1) AU1774600A (es)
BR (1) BR9915735A (es)
CA (1) CA2351631A1 (es)
CO (1) CO5140118A1 (es)
DE (2) DE69938193D1 (es)
ES (1) ES2158813B1 (es)
FR (1) FR2786179B1 (es)
GB (1) GB2343894B (es)
IT (1) IT1308657B1 (es)
PE (1) PE20001401A1 (es)
TR (1) TR200101397T2 (es)
WO (1) WO2000031033A1 (es)
ZA (1) ZA200103940B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2250132T3 (es) 1999-05-18 2006-04-16 Teijin Limited Remedios preventivos para enfermedades asociadas a quimioquinas.
CA2378499A1 (en) 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
CA2423251A1 (en) 2000-09-29 2002-04-04 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases
DE60130684T2 (de) * 2000-12-19 2008-08-14 F. Hoffmann-La Roche Ag Substituierte pyrrolidine als ccr-3-rezeptorantagonisten
WO2002088111A1 (fr) 2001-04-27 2002-11-07 Mitsubishi Pharma Corporation Nouveaux composes de benzylpiperidine
GB0114699D0 (en) * 2001-06-15 2001-08-08 Novartis Ag Organic compounds
TW200303304A (en) 2002-02-18 2003-09-01 Astrazeneca Ab Chemical compounds
AU2004215679A1 (en) * 2003-02-27 2004-09-10 F. Hoffmann-La Roche Ag CCR-3 receptor antagonists
JP4736043B2 (ja) 2003-03-14 2011-07-27 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
WO2004092169A1 (ja) 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
SG131946A1 (en) * 2003-10-24 2007-05-28 Hoffmann La Roche Ccr3 receptor antagonists
SE0400208D0 (sv) 2004-02-02 2004-02-02 Astrazeneca Ab Chemical compounds
ES2396419T3 (es) 2004-09-08 2013-02-21 Mitsubishi Tanabe Pharma Corporation Compuestos de morfolina para el tratamiento de inflamaciones
TWI400232B (zh) 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
JPWO2006129679A1 (ja) 2005-05-31 2009-01-08 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200734305A (en) * 2005-08-02 2007-09-16 Astrazeneca Ab New salt III
TW200738635A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
EP2657235A1 (en) 2005-10-28 2013-10-30 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
ES2407115T3 (es) 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compuesto que contiene un grupo básico y uso del mismo
AU2007225836A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
US8618122B2 (en) 2006-05-16 2013-12-31 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
JP5245827B2 (ja) 2006-07-31 2013-07-24 小野薬品工業株式会社 スピロ結合した環状基を含有する化合物およびその用途
DE102008020746A1 (de) * 2008-04-25 2009-10-29 Saltigo Gmbh Verfahren zur Herstellung von quarternären Salzen von Piperidyl Estern der Mandelsäure
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
KR101180174B1 (ko) * 2010-04-23 2012-09-05 동아제약주식회사 신규한 벤즈아미드 유도체
EP3026049B1 (en) 2013-07-25 2021-09-22 Dong-A ST Co., Ltd. Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
US4163784A (en) * 1978-03-09 1979-08-07 Pfizer Inc. Heterocyclylcarbonyl derivatives of urea, agents for dissolution of gallstones
DK159420C (da) 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
US4579947A (en) 1983-06-16 1986-04-01 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted phenylalkylpiperazinylpropyl (ureas or thioureas) useful for treatment of immunological, inflammatory and allergic disorder
DK623586A (da) 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
US4857330A (en) 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
CA2005741C (en) 1988-12-26 1998-06-02 Hiroyoshi Hidaka Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
FI97540C (fi) 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
JPH041128A (ja) 1990-03-07 1992-01-06 Ajinomoto Co Inc 抗不整脈薬
US5143923B1 (en) 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
FR2677019B1 (fr) 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
DK60893D0 (da) 1993-05-26 1993-05-26 Novo Nordisk As Piperidinderivater, deres fremstilling og anvendelse
AU6954194A (en) 1993-06-23 1995-01-17 Merrell Dow Pharmaceuticals Inc. Piperidin-1-yl-2,2-dialkylpropanonearylsulfonamide derivatives
EP0661266A1 (en) 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
DE69527072T2 (de) 1994-08-19 2003-02-13 Abbott Lab Endothelin antagoniste
JPH0977742A (ja) * 1995-09-12 1997-03-25 Kyorin Pharmaceut Co Ltd 新規なベンズアミド誘導体
CA2188485A1 (en) 1995-11-17 1997-05-18 Ronald J. Mattson Piperidinylethylamide derivatives as serotonergic agents
GB9523526D0 (en) 1995-11-17 1996-01-17 Zeneca Ltd Therapeutic compounds
CA2197364A1 (en) 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JP4150435B2 (ja) * 1996-04-18 2008-09-17 株式会社資生堂 アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤
US6323206B1 (en) * 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TW498067B (en) 1996-07-19 2002-08-11 Hoffmann La Roche 4-hydroxy-piperidine derivatives
CA2261633A1 (en) 1996-07-29 1998-02-05 Banyu Pharmaceutical Co., Ltd. Chemokine receptor antagonists
US6136827A (en) 1997-07-25 2000-10-24 Merck & Co., Inc. Cyclic amine modulations of chemokine receptor activity
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6433165B1 (en) * 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2350903A1 (en) 1998-11-20 2000-06-02 F. Hoffmann-La Roche Ag Pyrrolidine derivatives-ccr-3 receptor antagonists
EP1156807A4 (en) 1998-12-18 2002-04-03 Du Pont Pharm Co N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS

Also Published As

Publication number Publication date
DE19955793A1 (de) 2000-05-25
ES2158813A1 (es) 2001-09-01
ATE386720T1 (de) 2008-03-15
WO2000031033A1 (en) 2000-06-02
BR9915735A (pt) 2001-09-04
EP1131290A1 (en) 2001-09-12
IT1308657B1 (it) 2002-01-09
ZA200103940B (en) 2002-08-15
FR2786179A1 (fr) 2000-05-26
GB2343894B (en) 2001-07-25
GB9927228D0 (en) 2000-01-12
JP3421323B2 (ja) 2003-06-30
ITTO991021A0 (it) 1999-11-22
ITTO991021A1 (it) 2001-05-22
TR200101397T2 (tr) 2001-11-21
FR2786179B1 (fr) 2001-08-10
GB2343894A (en) 2000-05-24
CN1326440A (zh) 2001-12-12
JP2002530375A (ja) 2002-09-17
AR029151A1 (es) 2003-06-18
EP1131290B1 (en) 2008-02-20
PE20001401A1 (es) 2000-12-15
DE69938193D1 (de) 2008-04-03
KR20010081034A (ko) 2001-08-25
US6342509B1 (en) 2002-01-29
ES2158813B1 (es) 2002-03-16
CA2351631A1 (en) 2000-06-02
AU1774600A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
CO5140118A1 (es) Sales de piperidinas 4-substituidas y n-substituidas
AR016822A1 (es) Un compuesto derivado de amina ciclica, su uso, un proceso para fabricar compuestos utiles como intermediarios para fabricarlo, y una composicionfarmaceutica que lo comprende
CO5140119A1 (es) 3-substituido-n-(hetero)arilalquil-pirrolidinas
AR016009A1 (es) Isotiazolcarboxiamidas, procedimiento para su obtencion, composiciones, su empleo en la proteccion de plantas contra el ataque por parte de microorganismos indeseables, y de insectos, arácnidos y nematodos, y procedimiento para la obtencion de dichas composiciones
ES2196772T3 (es) Compuestos amino ciclicos.
YU46803A (sh) Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
CA2423103A1 (en) N-acylsulfonamide apoptosis promoters
ES2175834T3 (es) Nuevos analogos tretaciclicos de camptotecinam, sus procedimientos de preparacion, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
AR061008A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo
AR012032A1 (es) Compuestos derivados 3&#39;-n-oxido, 3&#39;-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
NO961655L (no) Visse sammensmeltede pyrrolkarboksanilider; en ny klasse GABA-hjernereseptorligander
AR040030A1 (es) Moduladores biciclicos de la funcion del receptor de androgeno
CO5271658A1 (es) Antagonistas del factor liberador de corticotropina
CA2475432A1 (en) 2,4,6-triamino-1,3,5-triazine derivative
CO5570702A2 (es) N-sulfonilo-4-metileneamino-3-hidroxilo-2-piridonas como agente antimicrobiano
ATE357142T1 (de) 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen
CO4980859A1 (es) Arilpiperazinas que tienen actividad sobre el receptor 1a de la serotonina
CO5380019A1 (es) Azalidas de 13 miembros utiles como agentes antibioticos
YU18999A (sh) Supstituisani tricikli
NZ307505A (en) Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
AR011425A1 (es) Compuestos derivados de sulfamida, su uso, composiciones farmaceuticas que los comprenden y un procedimiento para preparar compuestos derivados de sulfamida
CO5170498A1 (es) Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
ES2194683T3 (es) Nuevos derivados siliciados de bencimidazol-benzazoles n-sustituidos o de bezofuranil-benzazoles filtros; composiciones cosmeticas fotoprotectoras que los contienen y utilizacion.
CO4990960A1 (es) Derivados de cetolidos 2-halo-6-o sustituidos